BI 3034701 for Overweight or Obesity with Complications

A Study to Test How Well Different and Multiple Doses of BI 3034701 Are Tolerated in People Living With Overweight or Obesity

Recruiting Phase 1 Interventional Study
Overweight Obesity
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Age
18 – 74
Sex
Any
Trial phase
Phase 1
Study type
Interventional
Purpose
Treatment
Participants needed
70 (estimated)
Sponsor
Boehringer Ingelheim · Industry
Who this trial is looking for

This trial is looking for adults who are overweight or obese and have at least one related health issue. Participants will receive an injection of the study drug and will be monitored for safety and how well they tolerate different doses.

Are You a Good Fit for This Trial?

You may be able to join if

  • I am between 18 and 74 years old.
  • I have a body mass index (BMI) between 27 and 39.9.
  • I have been diagnosed with at least one weight-related health issue.
  • I am otherwise healthy as determined by a medical exam.
  • I can provide signed consent to participate.

You may not be able to join if

  • I have abnormal medical exam results that my doctor considers important.
  • I have specific blood pressure or pulse rate measurements outside normal ranges, unless related to my weight issue.
  • I have serious laboratory test results that could affect my participation.
  • I have impaired kidney function or need dialysis.

Summarized in plain language from this trial's official eligibility criteria. The full criteria are further down this page — only the research team can confirm whether you qualify.

Think this trial could be right for you?

Answer three quick questions written from this study's own rules to see if you may qualify. No account needed to find out.

Check Your Eligibility
About This Trial

The main objectives of this trial are to investigate safety, tolerability of alternative dose titration strategies and pharmacokinetics (PK) of BI 3034701 in participants with overweight / obesity and at least one weight related co-morbidity following subcutaneous administration.

Trial Locations
Loading…

Loading trial locations…

Eligibility Criteria
Inclusion criteria : 1. Male or female trial participant, overweight/obese with one weight related complication but otherwise healthy according to the assessment of the investigator, as based on a complete medical history including a physical examination, vital signs (blood pressure (BP), pulse rat…
Contacts

Boehringer Ingelheim

1-800-243-0127

clintriage.rdg@boehringer-ingelheim.com

CONTACT